High-dose-rate versus low-dose-rate monotherapy in the treatment of localized prostate cancer: The case for low-dose-rate monotherapy
To access this article, please choose from the options below
PII: S1538-4721(06)00005-5
doi:10.1016/j.brachy.2006.01.003
© 2006 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
